Park Edge Advisors, LLC Bristol Myers Squibb CO Transaction History
Park Edge Advisors, LLC
- $310 Million
- Q3 2024
A detailed history of Park Edge Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Park Edge Advisors, LLC holds 14,777 shares of BMY stock, worth $778,156. This represents 0.25% of its overall portfolio holdings.
Number of Shares
14,777
Previous 15,377
3.9%
Holding current value
$778,156
Previous $638,000
19.75%
% of portfolio
0.25%
Previous 0.22%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,438Shares Held
1.51BCall Options Held
29.7MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$9.82 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.35 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.82 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.93 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.11 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $112B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...